4
Changes in Ownership
AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-20-000041
Chief Medical Officer sold 3,583 shares at $50.01 ($179,200)
- Chief Medical Officer acquired 3,583 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Bowden Christopher · Chief Medical Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-05-20 | Exercise or conversion : show line 1 in the form | +3,583 | $35.16 | $125,978 | 11,889 | D |
| 2020-05-20 | Sale : show line 2 in the form | −3,583 | $50.01 | $179,200 | 8,306 | D |
| Open-market sales · 3,583 sh · avg $50.01 · $179,200 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2020-05-20 | Exercise or conversion : show line 3 in the form Stock option (right to buy) | −3,583 | 15,723 | D |
Loading xslF345X03/wf-form4_159009512439488.xml…